By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


United Therapeutics Corporation 

1110 Spring Street

Silver Spring  Maryland  20910  U.S.A.
Phone: 301-608-9292 Fax: 301-608-9291



Company News
Clinigen Group And United Therapeutics (UTHR) Initiate Managed Access Program For UNITUXIN (Dinutuximab) Injection For High Risk Neuroblastoma 11/4/2015 2:06:39 PM
United Therapeutics (UTHR) Reports Third Quarter 2015 Financial Results 10/27/2015 11:34:08 AM
United Therapeutics (UTHR) To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015 10/21/2015 11:53:40 AM
SteadyMed (STDY) Files Inter Partes Review To Invalidate United Therapeutics (UTHR) Patent 10/21/2015 7:34:30 AM
United Therapeutics (UTHR) Announces Additional $500 Million Share Repurchase Program 10/15/2015 8:08:22 AM
United Therapeutics (UTHR) Announces Settlement Of Patent Litigation With Sandoz 9/30/2015 6:59:41 AM
Synthetic Genomics, Inc. Expands Collaborative Research And Development Agreement With Lung Biotechnology PBC, A Subsidiary Of United Therapeutics (UTHR), To Develop Organs For Transplantation 9/23/2015 11:21:46 AM
AbbVie (ABBV) Forks Over $350 Million Cash to United Therapeutics (UTHR) for Rare Pediatric Disease Priority Voucher 8/19/2015 6:18:43 AM
United Therapeutics Corporation (UTHR) Release: European Commission (EC) Grants Marketing Authorisation For Unituxin (dinutuximab) For The Treatment Of Paediatric High-Risk Neuroblastoma 8/17/2015 6:49:20 AM
United Therapeutics Corporation (UTHR) To Present At The 2015 Wedbush PacGrow Healthcare Conference 8/6/2015 1:34:36 PM